| Announce Date | 10/22/2025 | 
| EPS Normalized Actual | $0.546 (Beat by $0.156) | 
| EPS GAAP Actual | $0.546 (Beat by $0.156) | 
| Revenue Actual | $3.385B | 
| Revenue Surprise | Beat by $3385M | 
| Announce Date | 12/31/1969 (Pre-Market) | 
| EPS Normalized Estimate | $ | 
| EPS GAAP Estimate | $ | 
| Revenue Estimate | $0B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2029 | 2.49372 | 17.28 | 2.16156 | 2.87382 | 10 | 
| Dec 2028 | 5.09652 | 8.45 | 4.09207 | 6.98911 | 9 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.58 | 0.58 | 3.385B | 100% | 3385M | 
| FQ2 2025 (Jun 2025) | 0.42 | 0.42 | 2.023B | -91.45% | 2023M | 
| FQ1 2025 (Mar 2025) | 0.74 | 0.74 | 2.29B | -74.15% | 2290M | 
| FQ4 2024 (Oct 2024) | 0 | 0 | 0B | -INF% | 0M | 
| FQ2 2024 (Jun 2024) | 0.7 | 0.7 | 3.873B | 9.14% | 3873M | 
| FQ1 2024 (Mar 2024) | 0.66 | 0.66 | 3.988B | 5.09% | 3988M | 
| FQ4 2023 (Dec 2023) | 0.93 | 0.93 | 4.108B | 55.5% | 4108M | 
| FQ3 2023 (Sep 2023) | 0.53 | 0.53 | 3.599B | 100% | 3599M | 
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 0.42159 | -- | 0.3726 | 0.48911 | 7 | 
| FQ3 2028 (Sep 2028) | 0.36153 | -- | 0.36153 | 0.36153 | 7 | 
| FQ2 2028 (Jun 2028) | 0.35433 | -- | 0.35433 | 0.35433 | 7 | 
| FQ1 2028 (Jan 2028) | 0.91538 | -- | 0.83733 | 1.01702 | 8 | 
| FQ4 2027 (Oct 2027) | 1.07071 | -- | 0.97941 | 1.1896 | 6 | 
| FQ3 2027 (Jul 2027) | 1.06975 | -- | 0.97854 | 1.18853 | 3 | 
| FQ2 2027 (Apr 2027) | 1.09283 | -- | 0.99965 | 1.21418 | 3 | 
| FQ1 2027 (Jan 2027) | 0.55831 | -- | 0.5107 | 0.6203 | 6 | 
| FQ4 2026 (Dec 2026) | 0.8765 | -- | 0.80473 | 0.98146 | 8 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 2.51B | -- | 2.28B | 2.82B | 7 | 
| FQ3 2028 (Sep 2028) | 2.49B | -- | 2.49B | 2.49B | 5 | 
| FQ2 2028 (Jun 2028) | 2.49B | -- | 2.49B | 2.49B | 5 | 
| FQ1 2028 (Jan 2028) | 0B | -- | 0B | 0B | 0 | 
| FQ4 2027 (Oct 2027) | 0B | -- | 0B | 0B | 0 | 
| FQ3 2027 (Jul 2027) | 0B | -- | 0B | 0B | 0 | 
| FQ2 2027 (Apr 2027) | 0B | -- | 0B | 0B | 0 | 
| FQ1 2027 (Jan 2027) | 3.05B | -- | 2.85B | 3.32B | 5 | 
| FQ4 2026 (Dec 2026) | 2.74B | -- | 2.57B | 2.99B | 1 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.58 | 0.58 | 100% | |
| FQ2 2025 (Jun 2025) | 0.42 | 0.42 | 100% | |
| FQ1 2025 (Mar 2025) | 0.74 | 0.74 | 100% | |
| FQ4 2024 (Oct 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0.7 | 0.7 | 100% | |
| FQ1 2024 (Mar 2024) | 0.66 | 0.66 | 100% | |
| FQ4 2023 (Dec 2023) | 0.93 | 0.93 | 100% | |
| FQ3 2023 (Sep 2023) | 0.53 | 0.53 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $3.39B | $3385M | 100% | 
| FQ2 2025 (Jun 2025) | $0B | $2.02B | $2023M | 100% | 
| FQ1 2025 (Mar 2025) | $0B | $2.29B | $2290M | 100% | 
| FQ4 2024 (Oct 2024) | $0B | $0B | $0M | NAN% | 
| FQ2 2024 (Jun 2024) | $0B | $3.87B | $3873M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $3.99B | $3988M | 100% | 
| FQ4 2023 (Dec 2023) | $0B | $4.11B | $4108M | 100% | 
| FQ3 2023 (Sep 2023) | $0B | $3.6B | $3599M | 100% |